The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-((3,4-Difluorophenyl)thio)-2-hydroxy-2-methyl-N-(4-nitro-2-(trifluoromethyl)phenyl)propanamide ID: ALA4549796
PubChem CID: 155550281
Max Phase: Preclinical
Molecular Formula: C17H13F5N2O4S
Molecular Weight: 436.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(O)(CSc1ccc(F)c(F)c1)C(=O)Nc1ccc([N+](=O)[O-])cc1C(F)(F)F
Standard InChI: InChI=1S/C17H13F5N2O4S/c1-16(26,8-29-10-3-4-12(18)13(19)7-10)15(25)23-14-5-2-9(24(27)28)6-11(14)17(20,21)22/h2-7,26H,8H2,1H3,(H,23,25)
Standard InChI Key: JGEITDDJBCVTLM-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 30 0 0 0 0 0 0 0 0999 V2000
15.8343 -20.4053 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.4122 -19.1719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4111 -19.9994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1259 -20.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8424 -19.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8396 -19.1682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1242 -18.7592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6963 -20.4113 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9821 -19.9983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2671 -20.4102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9827 -19.1732 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5530 -19.9970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6760 -20.9929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8469 -20.9929 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1239 -19.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1242 -19.1781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4148 -18.7687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7041 -19.1793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7073 -20.0033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4174 -20.4090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1257 -21.2373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4111 -21.6497 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.8401 -21.6500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.1179 -22.0596 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.5547 -18.7517 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5515 -17.9266 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.2707 -19.1616 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9946 -20.4189 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.9888 -18.7681 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 2 2 0
3 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 1 1 0
10 13 1 0
10 14 1 0
1 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
4 21 1 0
21 22 1 0
21 23 1 0
21 24 1 0
25 26 2 0
25 27 1 0
6 25 1 0
19 28 1 0
18 29 1 0
M CHG 2 25 1 27 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 436.36Molecular Weight (Monoisotopic): 436.0516AlogP: 4.37#Rotatable Bonds: 6Polar Surface Area: 92.47Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.14CX Basic pKa: ┄CX LogP: 4.31CX LogD: 4.31Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.30Np Likeness Score: -1.67
References 1. Bassetto M, Ferla S, Pertusati F, Kandil S, Westwell AD, Brancale A, McGuigan C.. (2016) Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer., 118 [PMID:27131065 ] [10.1016/j.ejmech.2016.04.052 ]